Monoclonal Antibody Therapy in Treating Patients With Recurrent Non-Hodgkin's Lymphoma

NCT00004101 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

NIH

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: apolizumab

Sponsor

National Cancer Institute (NCI)